GMP Cytokines Market Size, Share, Growth, and Industry Analysis by Type (TNF, Interleukin, Growth Factor, and Others) By Application (Cell/Gene Therapy, Tissue-Engineered Products, and Others) Regional Forecast From 2025 To 2034

•   
•   
  

  Request a Free sample to learn more about this report

    

GMP CYTOKINES MARKET OVERVIEW

The global GMP Cytokines Market size stood at USD 0.2 billion in 2025, growing further to USD 0.46 billion by 2034 at an estimated CAGR of 9.58% from 2025 to 2034.

The United States GMP Cytokines Market size is projected at USD 0.06138 billion in 2025, the Europe GMP Cytokines Market size is projected at USD 0.05055 billion in 2025, and the China GMP Cytokines Market size is projected at USD 0.06398 billion in 2025.

Innate and adaptive immunity, which allow immune system cells to communicate over short distances, are significantly regulated by cytokines. An important component of the treatment has been the use of cytokine therapy to stimulate the immune systems of cancer patients. Additionally, some cytokines indirectly suppress the growth of tumors by encouraging immune cells to attack tumor cells with cytotoxicity. The segment is projected to develop during the forecast period due to extensive investigations on these GMP cytokines

Globally, there has been a lot of studies done on stem cells to enhance human health. The restoration and regeneration of damaged tissues heavily rely on stem cells. Numerous scientists have argued that stem cells could likely produce novel treatments for a variety of chronic conditions, including cancer and cardiovascular disease, based on significant research on the subject. For instance, a 2018 study titled "Nonconventional induction strategies for the production of recombinant human tumor necrosis factor-alpha in Escherichia coli" examined the kinetics of recombinant human TNF- production in Escherichia coli under three different nonconventional inducible expression systems—salt, thermal, and auto-inducible systems in batch culture.

KEY FINDINGS

COVID-19 IMPACT

Halt on Manufacturing Operations to Slower Market Growth 

The water, energy, ecological, and food industries are all being significantly impacted by the COVID-19 epidemic. The GMP cytokines market has persisted worldwide despite the challenging conditions. Contrarily, a lack of labor, a tight budget, and issues with the supply chain have all impeded the provision of services. As a result, it is difficult to predict how the COVID-19 epidemic may affect the world GMP cytokines market.

LATEST TRENDS

Significant Investments and Partnerships in GMP Cytokines Market to Boost Market Growth

During the projected period, the GMP cytokines market is likely to be driven by significant investments and partnerships. In addition, the growing number of investments and partnerships to create cytokine therapies for the treatment of autoimmune and cancer would speed up the GMP cytokines market in the upcoming years. Additionally, a vastly increased number of product launches for stem cell therapies are being extended to support GMP cytokines market growth. For instance, CEVEC and CellGenix announced the release of GMP TGF-ß1 for the cell and gene therapy sector in December 2019. During the projected period, it is anticipated that such product introductions will accelerate the growth of the GMP cytokines market.

• Autoimmune disease incidence continues rising: conditions like rheumatoid arthritis, MS, and IBD increasingly drive need for cytokine‑based therapies.

• Immunotherapy adoption, especially T‑cell and NK‑cell therapies, is boosting demand for GMP cytokines in cell manufacturing workflows.

•   
•   
  

  Request a Free sample to learn more about this report

    

GMP CYTOKINES MARKET SEGMENTATION

By Type Analysis

As per the type, the market is classified as follows: TNF, Interleukin, Growth Factor, and Others. The TNF sector is anticipated to increase at the quickest CAGR throughout the projected period, while the growth factors segment held the greatest GMP cytokines market share in 2024.

By Application Analysis

Based on application, the market is segmented as follows: Cell/Gene Therapy, Tissue-Engineered Products, and Others. The GMP cytokines market's greatest share in 2019 belonged to the cell and gene therapy category, but throughout the forecast period, tissue-engineered products are predicted to grow at the highest CAGR.

DRIVING FACTORS

Potential Role of GMP Cytokines in Stem Cell Therapy to Facilitate Market Development

The rise in acceptance of cytokine cancer and autoimmune therapies as well as their potential role in stem cell therapy are the key causes of the GMP cytokines market's expansion. The GMP cytokines market is projected to experience growth during the forecast period as a result of the cytokines therapies' effectiveness and the disease's rising prevalence. The World Health Organization (WHO) estimates that cancer claimed 9.6 million lives globally in 2019. Additionally, cancer affected 29.2 million people worldwide. Similarly, to this, it is anticipated that the increasing incidence of autoimmune illnesses would accelerate the use of cytokine-based treatments. As a result, the benefits of cytokine therapy in the treatment of autoimmune and cancer disorders, as well as the rising prevalence of these diseases, are driving up the demand for GMP cytokines therapies.

Advancement in Technology and Research to Promote Industry Progress

The use of stem cells for new treatments is being aided by the GMP cytokines growth factor thanks to advancements in technology and research. GMP cytokines used in hematopoietic stem cell therapy are crucial in controlling a variety of hematopoietic stem cell characteristics, including self-renewal, quiescence, apoptosis, differentiation, and mobilization. Additionally, the growth factors are in charge of the interactions between a number of additional growth factors and hormones that help these cells' receptors bind.

• Autoimmune disease incidence continues rising: conditions like rheumatoid arthritis, MS, and IBD increasingly drive need for cytokine‑based therapies.

• Immunotherapy adoption, especially T‑cell and NK‑cell therapies, is boosting demand for GMP cytokines in cell manufacturing workflows.

RESTRAINING FACTORS

High Cost of GMP Cytokines to Hinder Market Growth

As they enable close-quarters contact between immune system cells, GMP cytokines play a critical role in the regulation of innate and adaptive immunity. Cytokine therapy, which aids in immune system activation, has long been a crucial component of cancer patient care and is still a major force in current clinical cancer research. The creation of unique, pricey products has been driven by incredibly advanced requirements from researchers in the life sciences field. The high cost of GMP cytokines treatment, however, is anticipated to impede market expansion.

• High production complexity: GMP cytokine manufacturing demands specialized equipment and strict purity/stability controls, raising cost hurdles.

• Therapy affordability issues: steep prices of GMP cytokines limit reach in developing healthcare systems, slowing broader clinical uptake.

•   
•   
  Request a Free sample to learn more about this report

    

GMP CYTOKINES MARKET REGIONAL INSIGHTS

Rising Cancer Prevalence to Propel Market Progress in North America

The global GMP cytokines market was dominated by North America in 2019. The region's market expansion is due to elements including the region's active genomic research and rising cancer prevalence. Numerous companies in this area are investing money in R&D as well as spreading knowledge about cancer and its treatments. Governments are also funding cancer research and programs that are related to it. For instance, the Canadian Institutes of Health Research (CIHR) allocated 16% of its overall grants and award investments, to cancer research. Additionally, the CIHR provided about US$ 68 million in funding for cancer immunotherapy research.

KEY MARKET PLAYERS

Market Players Focus on New Product Launches to Strengthen Market Position

Leading players in the market are adopting various strategies to expand their presence in the market. These include R&D investments and the launch of new, technologically-advanced products in the market. Some companies are also adopting strategies such as partnerships, mergers, and acquisitions to strengthen their market position.

• Bio‑Techne: Actively optimizing cytokine manufacturing to reduce waste and improve lot‑to‑lot consistency in T‑cell therapy processes.

• Akron Biotech: Featured among top industry players supplying GMP cytokines for cell/gene therapy pipelines globally.

List of Top Gmp Cytokines Companies

• Bio-Techne
• Akron Biotech
• Sino Biological
• Miltenyi Biotec
• Lonza
• ReproCELL
• PeproTech
• Creative Bioarray
• Almog
• CellGenix
• GE Healthcare

REPORT COVERAGE

The report covers overall market aspects, including market segmentation based on its type and application. The report depicts a diverse group of participants, including the market and potential market leaders. Major factors that are expected to drive major growth in the market. The factors anticipated to expand the market share are also included in the report to offer market insights. The estimated growth of the market in the forecast period is also included in the report. The regional analysis is completed to explain the region's dominance in the global market. The factors hindering the growth of the market are discussed in detail. The SWOT analysis of the market is depicted in the report. It contains all-inclusive market details.